JP2002533397A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533397A5
JP2002533397A5 JP2000590640A JP2000590640A JP2002533397A5 JP 2002533397 A5 JP2002533397 A5 JP 2002533397A5 JP 2000590640 A JP2000590640 A JP 2000590640A JP 2000590640 A JP2000590640 A JP 2000590640A JP 2002533397 A5 JP2002533397 A5 JP 2002533397A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
azepan
amide
ylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533397A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/030730 external-priority patent/WO2000038687A1/en
Publication of JP2002533397A publication Critical patent/JP2002533397A/ja
Publication of JP2002533397A5 publication Critical patent/JP2002533397A5/ja
Pending legal-status Critical Current

Links

JP2000590640A 1998-12-23 1999-12-21 プロテアーゼ阻害剤 Pending JP2002533397A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11363698P 1998-12-23 1998-12-23
US60/113,636 1998-12-23
US16458199P 1999-11-10 1999-11-10
US60/164,581 1999-11-10
PCT/US1999/030730 WO2000038687A1 (en) 1998-12-23 1999-12-21 Protease inhibitors

Publications (2)

Publication Number Publication Date
JP2002533397A JP2002533397A (ja) 2002-10-08
JP2002533397A5 true JP2002533397A5 (enExample) 2006-09-07

Family

ID=26811293

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590640A Pending JP2002533397A (ja) 1998-12-23 1999-12-21 プロテアーゼ阻害剤

Country Status (24)

Country Link
US (2) US20020147188A1 (enExample)
EP (1) EP1158986A4 (enExample)
JP (1) JP2002533397A (enExample)
KR (1) KR100630986B1 (enExample)
CN (1) CN1253441C (enExample)
AT (1) ATE411294T1 (enExample)
AU (1) AU768565B2 (enExample)
BR (1) BR9916488A (enExample)
CA (1) CA2356671A1 (enExample)
CZ (1) CZ20012277A3 (enExample)
DE (1) DE69939752D1 (enExample)
DZ (1) DZ2977A1 (enExample)
ES (1) ES2315456T3 (enExample)
GC (1) GC0000178A (enExample)
HK (1) HK1043536A1 (enExample)
HU (1) HUP0104768A3 (enExample)
IL (2) IL143142A0 (enExample)
NO (1) NO318910B1 (enExample)
NZ (1) NZ511710A (enExample)
PE (1) PE20001340A1 (enExample)
PL (1) PL350132A1 (enExample)
TR (1) TR200101869T2 (enExample)
UY (1) UY25874A1 (enExample)
WO (1) WO2000038687A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
JP2003513928A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034157A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1229912A4 (en) * 1999-11-10 2003-05-07 Smithkline Beecham Corp PROTEASE INHIBITORS
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1231921A4 (en) * 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
WO2001034159A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
AU1474601A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
JP2003513921A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
JP2003513956A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
AU1474701A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
NZ520588A (en) * 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
CO5280088A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Inhibidores de proteasa
CO5280093A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Metodos de tratamiento
AP2002002671A0 (en) * 2000-06-14 2002-12-31 Smithkline Beecham Corp Protease inhibitors.
EP1320370A4 (en) * 2000-09-01 2008-10-22 Smithkline Beecham Corp TREATMENT METHOD
HUP0301964A3 (en) * 2000-11-22 2007-09-28 Smithkline Beecham Corp Protease inhibitors
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
WO2002066035A2 (en) 2001-02-20 2002-08-29 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
AU2002342682A1 (en) * 2001-05-17 2002-11-25 Smithkline Beecham Corporation Protease inhibitors
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
AU2003263738A1 (en) * 2002-05-22 2003-12-02 Smithkline Beecham Corporation Protease inhibitors
EP1534292A4 (en) * 2002-05-22 2008-04-02 Smithkline Beecham Corp PROTEASE INHIBITORS
KR100962972B1 (ko) * 2002-07-26 2010-06-09 주식회사유한양행 1-페닐피페리딘-3-온 유도체 및 그의 제조방법
JP2006504719A (ja) * 2002-10-08 2006-02-09 メルク フロスト カナダ アンド カンパニー 骨粗しょう症の治療において有用なカテプシンk阻害剤としての4−アミノ−アゼパン−3−オン化合物
DK3549936T3 (da) 2003-04-11 2021-07-12 Ptc Therapeutics Inc 1,2,4-oxadiazol-benzoesyreforbindelse og dens anvendelse til nonsense-undertrykkelse og behandlingen af sygdom
ATE407673T1 (de) 2003-08-01 2008-09-15 Chugai Pharmaceutical Co Ltd Azol-verbindungen auf cyanoguanidin-basis als malonyl-coa decarboxylase-hemmer
WO2005011693A1 (en) 2003-08-01 2005-02-10 Chugai Seiyaku Kabushiki Kaisha Piperidine compounds useful as malonyl-coa decarboxylase inhibitors
ATE487475T1 (de) * 2003-08-01 2010-11-15 Chugai Pharmaceutical Co Ltd Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
CN1910175A (zh) * 2004-01-08 2007-02-07 默克弗罗斯特加拿大有限公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
WO2006029154A2 (en) * 2004-09-07 2006-03-16 Smithkline Beecham Corporation Novel compounds
US20090264479A1 (en) * 2005-07-26 2009-10-22 Cameron Black Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases
RU2462246C2 (ru) 2006-03-30 2012-09-27 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы получения функционального белка из днк, имеющей нонсенс-мутацию, и лечения нарушений, ассоциированных с ней
JP6000340B2 (ja) 2011-05-16 2016-09-28 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 肺高血圧症および/または心不全の治療および/または予防のためのカテプシンk阻害の使用
CN103275070A (zh) * 2013-05-10 2013-09-04 郑彪 调节单核细胞增殖的四环化合物及其应用
CA3174516A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
TW201729807A (zh) 2015-10-30 2017-09-01 Ptc治療公司 用於治療癲癇的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1195287B (it) * 1981-11-05 1988-10-12 Ausonia Farma Srl Derivato tiazolico,procedimento per la sua preparazione e relative composizioni farmaceutiche
JPH05140063A (ja) * 1991-11-19 1993-06-08 Suntory Ltd ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤
ES2124281T3 (es) * 1992-12-25 1999-02-01 Mitsubishi Chem Corp Derivados de alfa-aminocetonas.
CA2111930A1 (en) * 1992-12-25 1994-06-26 Ryoichi Ando Aminoketone derivatives
JPH06199850A (ja) * 1992-12-28 1994-07-19 Tanabe Seiyaku Co Ltd インドール含有ペプチド及びその製法
ATE201404T1 (de) * 1995-12-12 2001-06-15 Taiho Pharmaceutical Co Ltd Epoxysuccinamid-derivate oder deren salze und medikamente die diese enthalten
US5902882A (en) * 1996-04-17 1999-05-11 Hoffmann-La Roche Inc. Assymetric synthesis of azepines
DZ2285A1 (fr) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
US6107291A (en) * 1997-12-19 2000-08-22 Amgen Inc. Azepine or larger medium ring derivatives and methods of use
WO2001034599A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513956A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
JP2003513921A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
EP1231921A4 (en) * 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
JP2003513928A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
AU1474701A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) * 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
AU1474601A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
EP1229912A4 (en) * 1999-11-10 2003-05-07 Smithkline Beecham Corp PROTEASE INHIBITORS
NL1013996C2 (nl) * 1999-12-30 2001-07-03 Innas Free Piston Bv Vrijezuiger aggregaat voor opwekken van hydraulische energie.

Similar Documents

Publication Publication Date Title
JP2002533397A5 (enExample)
JP2003527429A5 (enExample)
CA2356671A1 (en) Protease inhibitors
JP5345140B2 (ja) プロトンポンプ阻害剤としての5員複素環化合物
TWI422583B (zh) 具有以4-吡啶烷硫基為取代基之新穎化合物
RU2004138079A (ru) Антагонисты рецептора-1 меланин-концентрирующего гормона (мсн1r)
CN101027295A (zh) 用于治疗炎性疾病的化合物和含它们的药物组合物
AU7288598A (en) Protease inhibitors
NZ518698A (en) Novel cyclopropanes as CGRP antagonists, medicaments containing said compounds and method for the production thereof
OA12323A (en) Protease inhibitors.
ZA200206361B (en) Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists.
EP1320370A1 (en) Method of treatment
CA2412353A1 (en) Protease inhibitors
JP2002536446A (ja) プロテアーゼ阻害剤としての、ヘテロアリールアミジン類、メチルアミジン類およびグアニジン類
US7405209B2 (en) Protease inhibitors
ZA200104208B (en) Protease inhibitors.
AU2001298052A1 (en) Protease inhibitors
JP2005232149A (ja) 4−ピリジルアルキルチオ基を置換基として有する新規化合物
US20030044399A1 (en) Method of treatment
MXPA01006613A (en) Protease inhibitors